Zenotech Laboratories Q2 FY27 Results: Net Loss of ₹2.6 Cr, Loss Widens
Zenotech Laboratories Ltd reported revenue from operations of ₹6.1 Cr (-40.2% YoY) and a net loss of ₹2.6 Cr for Q2 FY27.
- Key figure
- Net loss ₹2.6 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Zenotech Laboratories Ltd reported revenue from operations of ₹6.1 Cr (-40.2% YoY) and a net loss of ₹2.6 Cr for Q2 FY27.
Zenotech Laboratories will hold a board meeting on October 28, 2026, to consider and approve the unaudited financial results for the period ended September 30, 2026.
Zenotech Laboratories submitted the Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, confirming dematerialization activities performed by its registrar.
Zenotech Laboratories Limited concluded its 37th Annual General Meeting. Shareholders approved the adoption of financial statements and re-appointment of Mr. Jignesh Anantray Goradia as Director.
Zenotech Laboratories Limited will hold its 37th Annual General Meeting on September 25, 2026, via video conferencing. The cut-off date for voting is September 18, 2026.